Compare IDEXX Laboratories, Inc. (IDXX) vs Prologis Inc (PLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Prologis Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while Prologis Inc trades at $129.49 (market cap $122.87B). The key difference: Prologis Inc is far larger — about 3× IDEXX Laboratories, Inc.'s market cap, and Prologis Inc pays a 3.31% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Prologis Inc for 102 Days on average.
| IDXX | PLD | |
|---|---|---|
Market Cap | $40.43B | $122.87B |
Volume | 692,164 | 4,222,957 |
Sector | Health | Real Estate |
52-Week High | $766.68 | $149.96 |
52-Week Low | $504.70 | $111.23 |
Typical Hold Time | 46 Days | 102 Days |
Enterprise Value | $41.32B | $157.61B |
Dividend Yield | — | 3.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.27 exceeding the $3.94 estimate. Revenue grew to $4.3 billion in 2025, and net income margin expanded to 25.03%. Recent acquisitions like CoVetAI aim to enhance veterinary workflow intelligence.
The outlook remains positive given robust profitability and analyst consensus, but risks include foreign exchange headwinds and competitive pressures. With a consensus price target of $665, representing ~30% upside, the stock offers growth potential for investors comfortable with its premium valuation multiples.
Prologis (PLD) trades at $129.29, up 1.56% today, with a bearish technical signal from moving averages but strong fundamental performance. The company reported revenue of $8.79B in 2025 and has beaten EPS estimates for the last three quarters. Analyst consensus is bullish with a $155.15 price target, supported by robust leasing activity and data center growth, as highlighted in recent investor events (BofA Global Real Estate Conference, September 2026).
The outlook remains positive due to strong warehouse demand from e-commerce and data centers, though risks include rising debt levels and market volatility. With a P/E of 28.8 and net income margin of 45.79%, PLD offers growth potential, but investors should monitor debt-to-asset trends, which increased to 37.2% in 2025 from 34.05% in 2024.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Prologis Inc
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →
